A new Supreme Court ruling sets clear rules on the liability and exposure of patent holders in Israel, addressing a key question: can misleading the patent registrar by a patent applicant give competitors a right to the profits generated by that deception, and under what conditions. In a new podcast episode, Adv. Merav Lechem hosts Adv. Orly Alster, VP and General Counsel at Teva, and Adv. Ran Vogel of S. Horowitz, for a conversation on the risks and opportunities arising from the ruling, and practical ways to reduce exposure to claims under it.
